Apr 19, 2026
Trump Signs Executive Order to Accelerate Psychedelic Drug Reviews Including Controversial Ibogaine
President Trump signed an executive order directing the FDA to expedite reviews of psychedelic drugs including ibogaine, which has been embraced by combat veterans but remains controversial. The order was signed alongside podcast host Joe Rogan.
3 sources
00